Hyperbaric Oxygen Therapy (HBOT) as a Treatment for COVID-19 (COVID-19) Infection
NCT ID: NCT04343183
Last Updated: 2023-04-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2020-04-30
2020-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of Hyperbaric Oxygen Therapy to Treat COVID-19 Patients With Respiratory Distress
NCT04800120
Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial
NCT06267300
Oxygen Toxicity of HBOT in Chronic Brain Injury
NCT00592891
Effect of HBOT on Femoral Head Avascular Necrosis (AVN)
NCT06931301
One vs. Three Hyperbaric Oxygen Treatments for Acute Carbon Monoxide Poisoning
NCT00465855
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HBOT treatment group
Patients will receive hyperbaric oxygen therapy
Hyperbaric Oxygen Therapy
Hyperbaric Oxygen Therapy delivered at a specific uniformed pressure and duration.
Standard of Care group
Patients will not receive hyperbaric oxygen therapy and will receive the current standardized treatment protocol
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hyperbaric Oxygen Therapy
Hyperbaric Oxygen Therapy delivered at a specific uniformed pressure and duration.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Positive PCR COVID-19 testing
* CT evidence of interstitial opacity
* Oxygen saturation \<90% on room air
* pO2 = 55-70.
Exclusion Criteria
* Hemodynamic instability (MAP\<65)
* Bradycardia (HR\<50)
* History of seizure disorder
* Pneumothorax
* GFR\<30
* Hemodialysis
* Refractory anxiety/claustrophobia
* Current pregnancy
* Uncorrectable hypoglycemia
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ochsner Health System
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeffery S Kuo, MD
Role: STUDY_CHAIR
Ochsner Health System
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ochsner Medical Center
New Orleans, Louisiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00001051
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.